[Update of the ESC atrial fibrillation guidelines : From the DGK commission for clinical cardiovascular medicine].

Abstract

In 2024, the current ESC guidelines for the management of atrial fibrillation (AF) were published. Despite significant advances in the prevention, diagnosis and treatment of AF, it remains the most common sustained arrhythmia with a significant impact on patients, their caregivers and public health. The concise guidelines focus on evidence-based recommendations and their practical implementation supported by clear figures and treatment pathways. The holistic care for AF patients including their comorbidities is prioritized in a comprehensive AF-CARE concept. It comprises "C" for comorbidities and risk factor management, "A" for avoidance of stroke and thromboembolism, "R" for reduction of symptoms by rate and rhythm control and "E", evaluation and dynamic reassessment. Ablation is now the first-line therapy in paroxysmal AF. Current data on device detected AF and triggered AF are considered. Maximum involvement of the patient for informed, shared decision-making is suggested, supported by the parallel publication of patient guidelines.